UPMC Hilman Cancer Center — Pittsburgh, Pennsylvania

UPMC Hilman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

UPMC Hilman Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma.

Sponsors: Curis, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPMC Hilman Cancer Center?

UPMC Hilman Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPMC Hilman Cancer Center conducted?

UPMC Hilman Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma.

Is UPMC Hilman Cancer Center accredited by Crixeo Health?

UPMC Hilman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPMC Hilman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.